Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: A replication study

Journal of the Neurological Sciences

Volumn 189, Issue 1-2, 2001, Pages 93-98

  Caselli, Richard J ^a   Osborne, David ^a   Reiman, Eric M ^b   Hentz, Joseph G ^a   Barbieri, Carolyn J ^a   Saunders, Ann M ^c   Hardy, John ^d   Graff Radford, Neill R ^e   Hall, Geri R ^f   Alexander, Gene E ^g  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c DUKE UNIVERSITY   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF IOWA   (United States)

^g ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Aging; Alzheimer's disease; Apolipoprotein E; Frontal lobe; Memory; Preclinical

Indexed keywords

APOLIPOPROTEIN E4;

ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; FEMALE; FRONTAL LOBE; HOMOZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RISK; SHORT TERM MEMORY; WORKING MEMORY;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COGNITION DISORDERS; COHORT STUDIES; DEPRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 0035882109     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(01)00577-9     Document Type: Article

References (48)

1. Working-memory capacity, age, and memory for discourse
2. Age differences in recall and recognition
3. Aging, divided attention, and processing capacity
4. Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method
5. Positron emission tomography studies of normal aging: a replication of PET III and 18-FDG using PET IV and 11-CDG
6. PET demonstrates differential asymmetric and responses to various stimuli of regional brain glucose metabolism in healthy volunteers
7. Decreases of frontal metabolism demonstrated by positron emission tomography in a population of healthy elderly volunteers
8. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age
9. Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease: pathophysiologic implications
10. Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas
11. Posterior cingulate cortex in Alzheimer's disease
12. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET
13. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
14. Association of apolipoprotein E allele ε4 with late onset familial and sporadic Alzheimer's disease
15. Preclinical evidence of Alzheimer's disease in persons homozygous for the e4 allele for apolipoprotein E
16. Preclinical memory decline in cognitively normal apolipoprotein E-e4 homozygotes
17. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I
18. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change-report of a National Institute of Mental Health work group
19. Mild cognitive impairment: clinical characterization and outcome
20. Clinical diagnosis of Alzheimer's disease: report of the NINCDS/ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease
21. Population-based norms for the mini-mental state examination by age and education level
22. Amnesia and the distinction between long and short term memory
23. The neural basis of the central executive system of working memory
24. Working memory and the mind
25. The 'preclinical phase' of probable Alzheimer's disease: a 13-year prospective study of the Framingham cohort
26. Patterns of activation in people at risk for Alzheimer's disease
27. A longitudinal behavioral study of senile dementia of the Alzheimer type
28. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ε4 allele
29. Neuropsychological detection and characterization of preclinical Alzheimer's disease
30. Episodic memory changes are associated with the ApoE-ε4 allele in nondemented older adults
31. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study
32. Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease: a longitudinal prospective study
33. The consortium to establish a registry for Alzheimer's disease (CERAD): Part I. Clinical and neuropsychological assessment of Alzheimer's disease
34. Memory function in very early Alzheimer's disease
35. Neuropsychological prediction of dementia in healthy elderly persons
36. Working memory and secondary memory deficits in Alzheimer's disease
37. Short-term forgetting in senile dementia of the Alzheimer's type
38. Primary memory and secondary memory in dementia of the Alzheimer type
39. Dementia and working memory
40. Clinical and pathological evidence for a frontal variant of Alzheimer's disease
41. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation
42. Tracking the decline in cerebral glucose metabolism in persons and laboratory animals at genetic risk for Alzheimer's disease
43. The role of apolipoprotein E in Alzheimer's disease, acute brain injury, and cerebrovascular disease: evidence of common mechanisms and utility of animal models
44. Apolipoprotein E polymorphism and atherosclerosis
45. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: the Framingham offspring study
46. ApoE allele frequencies in younger (age 42-50) vs. older (age 65-90) women